Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020

SELL
$0.6 - $2.31 $6,000 - $23,100
-10,000 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$0.63 - $2.27 $6,300 - $22,700
10,000 New
10,000 $23,000
Q4 2018

Feb 14, 2019

SELL
$0.53 - $1.11 $22,525 - $47,175
-42,500 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$0.35 - $0.92 $14,874 - $39,100
42,500 New
42,500 $39,000

Others Institutions Holding MTNB

About Matinas BioPharma Holdings, Inc.


  • Ticker MTNB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 216,864,992
  • Market Cap $789M
  • Description
  • Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...
More about MTNB
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.